Global Blood Disease Trends in 2022
Blood Disease is part of Pathology. You may also be interested in Infectious Disease, Digestive System Disorder and Obesity.
Global sales of medicines used to treat conditions related to blood and blood forming organs are set to reach $30 billion by 2026. In 2021, this market was valued at $27.3 billion, an average annual growth rate of 1.6% since 2017. Japan was the leading market for these medicines in 2021, with sales of $5.9 billion. Germany, Italy and South Korea followed in second, third and fourth place respectively. Spain saw a 21.4% year-on-year growth in the market since 2017, while Greece experienced a 13.1% decline over the same period.
Top 10 countries
In 2022 major markets in the Blood Disease Industry were:
Blood Disease Market Data and Forecasts
How much the Blood Disease industry is expected to grow to 2026?
More in Blood Disease Industry for 2028Global Blood Disease Statistics
- In Patient Average Length Of Stay 68 countries (Europe, Northern Europe, Western Europe...)
- Hospital Number 63 countries (Europe, Northern Europe, Western Europe...)
- Anemia Prevalence 223 countries (Africa, Sub-Saharan Africa, Asia...)
- Child Mortality 241 countries (Europe, Northern Europe, Eastern Europe...)
- Blood And Blood Forming Organs Medicine Sales 46 countries (Europe, Northern Europe, Western Europe...)